Profile

• 2013: Medical Certificate, University of Athens
• 2017: Master’s Degree in Cardiopulmonary Resuscitation, University of Athens
• 2018: ESMO Preceptorship on Brain Tumors
• 2022: Virtual Kiel intense melanoma Clinical Observation Programme

• 2019-2023: Assistant Doctor for Medical Oncology, Metaxa Cancer Hospital, Piraeus
• 2018-2019: Associate Physician, 3rd Department of Medical Oncology, HYGEIA Hospital
• 2017: Assistant Doctor for Internal Medicine, Pammakaristos Hospital, Athens
• 2014-2016: Assistant Doctor for Internal Medicine, Metaxa Cancer Hospital, Piraeus
• 2013-2014: Medical Doctor, Greek army
• 2013: Practice in Internal Medicine – Surgery – Cardiology, Ruhr University Bochum, Germany

Melanoma, Breast cancer, Gastrointestinal malignancies, Central nervous system tumors

• 3/2023: Is the patient actually failing on enzalutamide? A case report and issues to consider in enzalutamide-resistant oligoprogressive castrate-resistant prostate cancer
• 3/2023: Immune checkpoint inhibitors and combinations with other agents in cholangiocarcinoma
• 8/2022: Can thromboprophylaxis build a link for cancer patients undergoing surgical and / or chemotherapy treatment? The METHOS cohort study
• 2/2022: Systemic treatment of Ewing Sarcoma: Current Options and Future Perspectives
• 1/2022: Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
• 12/2021: Case report: Combination of Olaparib with Chemotherapy in a patient with ATM-deficient colorectal cancer
• 10/2021: Case Report: Adenocarcinoma of the larynx with later hepatocellular differentiation
• 8/2021: Perforated appendicitis induced by pembrolizumab – A case report and review of the literature,
• 8/2021: An overview of current results with the Vincristine-Irinotecan-Temozolomide combination with or without Bevacizumab in pediatric, adolescense and adult solid tumors
• 7/2021: Central neurotoxicity induced by trastuzumab emtansine (T-DM1)-a case report
• 7/2021: High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy
• 6/2021: Immunotherapy for cholangiocarcinoma: a 2021 update
• 1/2021: Notable response of a young adult with recurrent glioblastoma multiforme to vincristine – irinotecan – temozolomide and bevacizumab
• 9/2020: Can thromboprophylaxis build a link for cancer patients undergoing surgical and / or chemotherapy treatment? Intermediate results from the METHOS study
• 1/2020: CNS Tumors in Adolescents and Young Adults: The Need for a Holistic Specialized Approach

• ESMO (European Society for Medical Oncology)
• ASCO (American Society for Clinical Oncology)

Participation in multicenter clinical trials